Headway against Brain Tumors with Molecular Targeting of IDH-Mutant Gliomas

N Engl J Med. 2023 Aug 17;389(7):653-654. doi: 10.1056/NEJMe2305639.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms* / drug therapy
  • Brain Neoplasms* / genetics
  • Brain Neoplasms* / pathology
  • Glioma* / drug therapy
  • Glioma* / genetics
  • Glioma* / pathology
  • Humans
  • Isocitrate Dehydrogenase / genetics
  • Molecular Targeted Therapy*
  • Mutation

Substances

  • Isocitrate Dehydrogenase
  • Antineoplastic Agents